Risk factors, biomarkers and potential preventative strategies are dicussed in this review article on chemotherapy-induced cardiotoxicity in breast cancer patients.
Browsing: Journals > Breast Cancer Management
In this Perspective from Breast Cancer Management, the authors discuss the role of anti-HER2 agents in breast cancer and their associated toxicities, as well as the evidence for concurrent administration of anthracyclines and HER2-targeted agents.
This editorial from Breast Cancer Management explores whether markers can be used to predict and prevent metastases at specific sites in breast cancer.
GE Healthcare introduces the contrast enhanced spectral mammography exam. With SenoBright, you can give your patients a confident diagnosis the same day, in the same place, in less than 7 minutes after the inconclusive mammogram.
This review discusses familial breast cancer susceptibility, the aims, logistics and vision of the 100,000 Genomes Project and how patients were recruited to the project.
Find out more about how the use of PET/CT scanning in stage II/III breast cancer could results in more individualized therapy plans for patients.
This review article discusses breast density and breast cancer risk, covering their correlation, the imaging modalities available to measure breast density and how such measures could aid in breast cancer prevention and treatment.
This article details a study carried out to assess the use of a survivorship care plan in breast cancer survivors, evaluating long-term use, care coordination and impact on quality of life.
Use of chemotherapy in breast cancer can increase the risk of venous thromboembolism. This Management Perspective article discusses the biology behind these thromboembolic events, and debates methods for diagnosis, risk stratification, management and prevention.